Oryzon Genomics SA (ES:ORY) has released an update.
Oryzon Genomics has announced a capital increase through the issuance of 500,789 new shares following a convertible bond conversion requested by Nice & Green SA, totaling approximately 919,999 euros in effective capital. The new shares, priced at 1.8371 euros each, will expand the company’s share capital to 3,200,592.90 euros. These shares will be admitted to trading on the main Spanish stock exchanges.
For further insights into ES:ORY stock, check out TipRanks’ Stock Analysis page.
